- The FDA announced that they recalled COVID tests from the Pharmaceutical company Celltrion
- The reason cited was them giving false positives
The FDA announced that a large number of COVID tests have been recalled from the Pharmaceutical company Celltrion USA – the reason given is that they were giving out a “high number of false-positive reports.”
The Food and Drug Administration announced Wednesday that a healthcare company has recalled 45,500 COVID-19 rapid tests due to a “high number of false positive reports.”
Pharmaceutical company Celltrion USA announced on Feb. 28 it is recalling specific lots of the DiaTrust COVID-19 Ag Rapid Test due to the high number of false-positive reports, an FDA recall webpage read on Wednesday.
The FDA says that a false-positive test result can lead to a delay in “the correct diagnosis and treatment for the actual cause of a person’s illness.”
The COVID-19 rapid tests also displayed a shelf life of 18 months, but the FDA’s emergency use authorization states that the tests can only be used for 12 months.
The Palmieri Report is a Pro-America News Outlet founded by Jacob Palmieri. The Palmieri Report is dedicated to giving people the truth so that they can form their own informed political opinions.
Follow us on social media:
Listen to our Daily News Podcast!